June 3, 2020
IRDiRC welcomes Illumina Inc. as new member to its Company Constituent Committee, which brings together representatives from the for-profit pharmaceutical and biotech members of IRDiRC.
Illumina is a global leader in genomics and strives to enable clinical laboratories worldwide the ability to offer best-in-class solutions needed to achieve a timely diagnosis and drive the adoption of whole genome sequencing (WGS) as standard of care.
In joining its forces with IRDiRC, Illumina hopes to shape a transformative future in which a bottleneck to diagnosis will be eradicated for the benefit of families living with rare and undiagnosed genetic diseases.
Dr. Volker Liebenberg is the Director of Medical Affairs EMEA at Illumina Inc. and he will represent the company in IRDiRC.